In March, we observe the two-year anniversary of providing care to COVID-19 patients at ÈËÆÞÖгöÊÓÆµ of Utah ÈËÆÞÖгöÊÓÆµ. Similar to the year prior, 2021 was unprecedented and marked with uncertainty over new emerging virus variants. Utah saw the number of daily positive infections and hospitalizations reach levels it has never seen before.
Delta surge
1,690 positive COVID-19 cases (highest 7-day average)
580 hospitalizations (highest 7-day average)
Omicron surge
10,600 positive COVID-19 cases (highest 7-day average)
830 hospitalizations (highest 7-day average)
COVID-19 Variants
Much of the uncertainty of the COVID-19 pandemic focused around new virus variants. In the last year, at least four prominent COVID-19 variants were identified. While the Brazil and South Africa variants did not have a direct impact on Utah, the Delta variant caused more severe disease and steadily drove up daily positive cases and ICU admissions at U of U ÈËÆÞÖгöÊÓÆµ.
During the peak of Delta (mid-September 2021), U of U ÈËÆÞÖгöÊÓÆµ saw:
In December 2021, Omicron became the next predominant variant in the U.S. and quickly made its way to Utah for another surge. Omicron, identified as more transmissible and contagious than Delta, once again put a strain on health care systems across the country and caused a heightened demand for COVID-19 testing. Because of this, U of U ÈËÆÞÖгöÊÓÆµ saw more hospitalizations than with any other previous variant. However, ICU admissions were less than half during the Delta surge due to Omicron causing much less severe disease.
During the peak of Omicron (mid-January 2022), U of U ÈËÆÞÖгöÊÓÆµ saw:
During both surges, COVID-19 vaccines helped prevent infection, hospitalization, and death. Though less effective at preventing infection (and breakthrough infection), the vaccines have been extremely effective in preventing hospitalization and death.
COVID-19 Vaccines
Several major milestones were achieved over the last year with COVID-19 vaccines. COVID-19 vaccines became available for , and full licensure was granted to both and Moderna COVID-19 vaccines. Additionally, COVID-19 were authorized for anyone ages 12 and older to further protect them from severe disease and hospitalization.
At U of U ÈËÆÞÖгöÊÓÆµ, COVID-19 vaccines and booster shots were administered at all community health centers. In the last year, U of U ÈËÆÞÖгöÊÓÆµ administered at least 150,370 COVID-19 vaccinations, including:
Since receiving COVD-19 vaccines at U of U ÈËÆÞÖгöÊÓÆµ, nearly 190,300 total vaccinations have been administered.
Treatments
More potential relief for SARS-CoV-2 infection became available to patients at U of U ÈËÆÞÖгöÊÓÆµ over the last year. While not as effective as COVID-19 vaccines, these COVID-19 treatments help reduce a person’s risk of becoming sicker and help those who may be more vulnerable to severe disease from the virus. Current COVID-19 treatments include:
Testing
U of U ÈËÆÞÖгöÊÓÆµ saw a demand for COVID-19 testing during the Delta and Omicron surges. At the peak of Delta, the health system tested about 250 patients a day in early September. However, during the Omicron surge, COVID-19 testing at U of U ÈËÆÞÖгöÊÓÆµ exceeded its testing capacity because of how contagious and transmissible Omicron became. At the peak of Omicron, test volumes reached more than 350 a day in mid-January.
At U of U ÈËÆÞÖгöÊÓÆµ:
Testing for SARS-CoV-2 is now more convenient than ever for patients at U of U ÈËÆÞÖгöÊÓÆµ with self-serve COVID-19 testing. In early 2022, U of U ÈËÆÞÖгöÊÓÆµ transformed COVID-19 testing by providing self-serve kiosks at seven community health centers just in time for the Omicron surge. These outdoor, temperature-controlled kiosks offer kits for saliva PCR or nasal swab PCR.
Research
The ÈËÆÞÖгöÊÓÆµ of Utah campus helped shape and unfold a better understanding of SARS-CoV-2 over the last year. The research response to COVID-19 has been life-changing and continues to be recognized on a global scale. To date, the to COVID-19 involves:
Some U of U ÈËÆÞÖгöÊÓÆµ research projects includes:
Campus, Community, and State Partnerships
​â¶Ä‹â¶Ä‹â¶Ä‹â¶Ä‹â¶Ä‹â¶Ä‹